Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics, Agilent Sign FISH Probe Supply Deal

NEW YORK (GenomeWeb) — Cancer Genetics said this week that it has signed a non-exclusive supply agreement with Agilent Technologies for probe reagents for its FISH-based HPV-Associated Cancer Test (FHACT).

CGI's test — a laboratory developed assay under CLIA in the US that also has CE marking — assesses genomic changes often found in cervical cancers to help identify patients who are at higher risk for disease progression.

Under the terms of the deal, Agilent will manufacture custom probes for CGI for use in the test. Rutherford, New Jersey-based CGI said it also intends to outlicense the probes through domestic and international distribution channels, with licensors able to purchase Agilent-manufactured probes.

Additional terms were not disclosed.

"This agreement marks an important milestone for Cancer Genetics and the company's FHACT test as it allows for expansion of our international business opportunities by outlicensing our probes, which is an integral part of the company's new strategy for revenue generation and path to profitability," CGI CEO John Roberts said in a statement.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.